格隆汇8月7日丨银诺医药-B(02591.HK)发布公告,公司拟全球发售3655.64万股H股(视乎发售量调整权及超额配股权行使与否而定),中国香港发售股份365.58万股,国际发售股份3290.06万股;2025年8月7日至8月12日招股;发售价将为每股发售股份18.68港元,每手买卖单位为200股,中信证券及中金公司为联席保荐人;预期股份将于2025年8月15日开始在联交所买卖。自2014年...
Source Link格隆汇8月7日丨银诺医药-B(02591.HK)发布公告,公司拟全球发售3655.64万股H股(视乎发售量调整权及超额配股权行使与否而定),中国香港发售股份365.58万股,国际发售股份3290.06万股;2025年8月7日至8月12日招股;发售价将为每股发售股份18.68港元,每手买卖单位为200股,中信证券及中金公司为联席保荐人;预期股份将于2025年8月15日开始在联交所买卖。自2014年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.